A Atsmon
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 7
-
- Kidney Stones and Urolithiasis Treatments 8
- Psychiatry and Mental health top 10%
-
- Neonatal Health and Biochemistry 15
-
- Porphyrin Metabolism and Disorders 29
- Heme Oxygenase-1 and Carbon Monoxide 12
- Biochemical and Molecular Research 4
-
- Metabolism and Genetic Disorders 11
-
- Folate and B Vitamins Research 8
- Co-authors
- I BlumNili SchoenfeldMeir SteinerN. SchoenfeldMeir LahavH WijsenbeekRivka MametAndré de Vries
- Partner nations
- IsraelUnited States
In The Last Decade
A Atsmon
75 papers receiving 919 citations
Peers
Comparison fields: 5 of 111
- Nephrology 111
- Complementary and Manual Therapy 22
- Pulmonary and Respiratory Medicine 295
- Psychiatry and Mental health 118
- Pediatrics, Perinatology and Child Health 139
Countries citing papers authored by A Atsmon
This map shows the geographic impact of A Atsmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Atsmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Atsmon more than expected).
Fields of papers citing papers by A Atsmon
This network shows the impact of papers produced by A Atsmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Atsmon. The network helps show where A Atsmon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Atsmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Porphyria and porphyrinuria]. | 1993 | 3 |
| 2 | 1991 | 3 | |
| 3 | 1990 | 4 | |
| 4 | 1989 | 3 | |
| 5 | 1988 | 46 | |
| 6 | 1988 | 9 | |
| 7 | Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test. | 1987 | 15 |
| 8 | 1985 | 3 | |
| 9 | [Lymphocyte uroporphyrinogen synthase in the diagnosis of lymphoma and its follow-up]. | 1985 | 1 |
| 10 | 1983 | 7 | |
| 11 | 1982 | 13 | |
| 12 | 1980 | 5 | |
| 13 | beta-adrenergic blocking drugs in psychiatry: present status, future approaches and research. | 1978 | 7 |
| 14 | 1978 | 22 | |
| 15 | 1977 | 9 | |
| 16 | The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Preliminary clinical observations. | 1971 | 36 |
| 17 | 1968 | 66 | |
| 18 | 1964 | 6 | |
| 19 | Nephrolithiasis in Israel. A study of its incidence, etiology and treatment. | 1961 | 1 |
| 20 | 1959 | 45 |
About A Atsmon
A Atsmon is a scholar working on Clinical Biochemistry, Nephrology, Pediatrics, Perinatology and Child Health, Rheumatology and Molecular Biology, having authored 81 papers that have together received 1.1k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (29 papers), Neonatal Health and Biochemistry (15 papers), Heme Oxygenase-1 and Carbon Monoxide (12 papers), Metabolism and Genetic Disorders (11 papers), Kidney Stones and Urolithiasis Treatments (8 papers), Folate and B Vitamins Research (8 papers), Gout, Hyperuricemia, Uric Acid (7 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Nephrology (111 citations), Complementary and Manual Therapy (22 citations), Pulmonary and Respiratory Medicine (295 citations), Psychiatry and Mental health (118 citations) and Pediatrics, Perinatology and Child Health (139 citations). A Atsmon has collaborated with scholars based in Israel and United States. Frequent co-authors include I Blum, Nili Schoenfeld, Meir Steiner, N. Schoenfeld, Meir Lahav, H Wijsenbeek, Rivka Mamet, André de Vries, Mati Shaklai and David Elson. Their work appears in journals such as Biochemical Pharmacology, Cancer, FEBS Letters, Journal of Molecular Biology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.